Our results parallel the findings from recent studies that revealed the co-expression of ACE2 and TMPRSS2 in olfactory epithelium [26] and intrahepatic cholangiocytes [27], which may explain atypical COVID-19 symptoms and laboratory findings such as anosmia/dysgeusia and transaminitis. This evidence concerns the gene ACE2 and COVID-19.